| 1. |
Gronberg BH,Bremnes RM,Flotten O,et al.Phase Ⅲ study by the Norwegian lung cancer study group:peme-trexed plus carboplatin compared with gemcitabine plus carboplatin asfirst-line chemotherapy in advanced non-small-cell lung cancer.J Clin Oncol,2009,27:3217-3224.
|
| 2. |
Scagliotti GV,Parikh P,von Pawel J,et al.Phase Ⅲ study comparing cisplatin plus gemcitabine with cisplatin pluspemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer.J Clin Oncol,2008,26:3543-3551.
|
| 3. |
Hanna N,Shepherd FA,Fossella FV,et al.Randomized phase Ⅲ trial of pemetrexed versus docetaxel in patients withnon-small-cell lung cancer previously treated with chemotherapy.J Clin Oncol,2004,22:1589-1597.
|
| 4. |
段建春,吳梅娜,趙軍,等.培美曲塞聯合鉑類藥物一線治療晚期非小細胞肺癌的療效及預測因素分析.中華結核和呼吸雜志,2012,35:97-101.
|
| 5. |
John W,Picus J,Blanke CD,et al.Activity of multitargeted antifolate (pemetrexed disodium,LY231514) in patients with advanced colorectal carcinoma:results from a phase Ⅱ study.Cancer,2000,88:1807-1813.
|
| 6. |
Pivot X,Raymond E,Laguerre B,et al.Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck.Br J Cancer,2001,85:649-655.
|
| 7. |
Worzalla JF,Shih C,Schultz RM.Role of folic acid in modulating the toxicity and efficacy of the multitargeted antifolate,LY231514.Anticancer Res,1998,18:3235-3239.
|
| 8. |
Rollins KD,Lindley C.Pemetrexed:a multitargeted antifolate.Clin Ther,2005,27:1343-1382.
|
| 9. |
Chattopahyay S,Moran RG,Goklman ID.Pemetrexed:biochemical and cellular pharmacology,mechanisms,and clinical applications.Mol Cancer,2007,6:404-417.
|
| 10. |
Molina JR,Adjei AA.The role of pemetrexed (Alimta LY231514) in lung cancertherapy.Clin Lung Cancer,2003,5:21-27.
|
| 11. |
Bajetta E,Celio L,Buzzoni R,et al.Phase Ⅱ study of pemetrexed disodium (Alimta) administered with oral folic acid inpatients with advanced gastric cancer.Ann Oncol,2003,14:1543-1548.
|
| 12. |
Takimoto CH,Hammond-Thelin LA,Latz JE,et al.Phase I and pharmacokinetic study of pemetrexed with high-dose folicacid supplementation or multivitamin supplementation in patients with locallyadvanced or metastatic cancer.Clin Cancer Res,2007,13:2675-2683.
|
| 13. |
Vogelzang NJ,Rusthoven JJ,Symanowski J,et al.Phase Ⅲ study of pemetrexed in combination with cisplatin versus cis-platin alone in patients with malignant pleural mesothelioma.J Clin Oncol,2003,21:2636-2644.
|
